The ALPS Medical Breakthroughs ETF (SBIO) focuses on late-stage biotech companies that have at least one Phase II or III clinical program and sufficient cash reserves to reduce dilution risk before key events. This strategy aims to capture upside from clinical catalysts and mergers or acquisitions, as demonstrated by recent acquisitions of top holdings. Despite the fund's high volatility and turnover, recent price pullbacks may offer investors a better entry point to gain exposure to promising late-stage biotech firms.
SBIO, the ALPS Medical Breakthroughs ETF, is noted here with Pluang's health sector data as context. For readers following health stocks, here is Pluang's market snapshot as of Sep 23, 2026 00:42 WIB: out of 100 priced US health-sector stocks, 75 rose and 25 fell. Notable movers include DGX at USD 234.76 with a -4.13% change and a typical hold time of 55 days, INO at USD 1.29 with a +4.03% change and 100% buy order activity, and TXG at USD 82.27 with a +4.01% change but 96% sell order activity and a typical hold time of 94 days.
MillerKnoll reported a strong Q1 2027 earnings per share (EPS) of $0.53, surpassing analyst expectations by over 51%, helped by tariff refunds and improved cost management. However, its revenue fell 3.4% year-over-year to $923.40 million, missing est...
Tether's CEO Paolo Ardoino revealed the company refused to seek EU MiCA authorization because the regulation requires major stablecoin issuers to hold at least 60% of their reserves in commercial bank deposits. Ardoino argues this concentration incre...
Candel Therapeutics has been upgraded from Buy to Strong Buy following successful phase 3 trial results for its prostate cancer treatment, aglatimagene. The trial showed a 30% reduction in disease recurrence risk, supporting a planned Biologics Licen...
Apple's new CEO, John Ternus, is under pressure from Washington to abandon a Chinese memory chip deal that former CEO Tim Cook fought to maintain. This comes as Apple faces rising memory costs, which have significantly impacted iPhone pricing and pro...
Bitcoin surged past $86,500, reaching a market cap above $3 trillion, driven by a bullish breakout and strong Nasdaq performance led by chipmakers. The Crypto Fear & Greed Index shows high investor greed, while altcoins also gained. Oil prices fell d...
